Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Unknown 180Completed 67Terminated 7Recruiting 4Withdrawn 2Not yet recruiting 2Enrolling by invitation 2Suspended 1Available 1

Sponsor Class

OTHER 14212INDUSTRY 3665OTHER_GOV 409NIH 330NETWORK 208FED 35UNKNOWN 4INDIV 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Lymphoid 1Head & Neck 1Gastrointestinal 1Breast 1

Conditions

Triple Negative Breast Neoplasms 1Recurrence 1Neoplasms 1Nasopharyngeal Carcinoma 1Lymphoma, Large B-Cell, Diffuse 1Esophageal Neoplasms 1

Interventions

pirarubicin 1pegylated granulocyte colony-stimulating factor 1Radiotherapy, Intensity-Modulated 1Platinum 1Paclitaxel 1Epirubicin 1Drug Therapy 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × UNKNOWN × Clear all
NCT06625203 2024-10-03

MOSAIC

OWKIN

Recruiting
7,000 enrolled
Lymphoid

Neoplasms, Lymphoma, Large B-Cell, Diffuse

NCT05145660 2022-09-27

Optimization of Cervical Nodal CTV for Early and Medium Stage NPC

ChineseAMS

Phase 3 Recruiting
414 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT04437160 2020-06-18

Adjuvant Chemotherapy for Triple Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy

ChineseAMS

Phase 2 Recruiting
286 enrolled
Breast

Triple Negative Breast Neoplasms

NCT03731442 2018-12-12

Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients

ChineseAMS

Phase 3 Recruiting
300 enrolled
Gastrointestinal

Esophageal Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡